Product

All Products

Image Product Name API Name Last Drug Patent Expires Details Year of start producing
CAS No. 1146629-83-5, (R)-3-(4-broMo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile CAS No. 1146629-83-5, (R)-3-(4-broMo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile Ruxolitinib 5/5/2041 (Ruxolitinib) View detail » 2022
Cas No. 591769-05-0, 3-Cyclopentylacrylonitrile Cas No. 591769-05-0, 3-Cyclopentylacrylonitrile Ruxolitinib 5/5/2041 (Ruxolitinib) View detail » 2016
Cas No. 941685-27-4, 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine Cas No. 941685-27-4, 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine Ruxolitinib, Baricitinib 5/5/2041 (Ruxolitinib); 11/30/2032 (Baricitinib) View detail » 2017